2017 annual financial data
Vistagen Therapeutics, Inc. 2017 Operating margin
Vistagen Therapeutics, Inc. 2017 operating margin with verified reported values.
Direct answer
Operating margin was -819.88%.
Operating income was -10,248,500 USD and net income was -10,255,500 USD.
Operating cash flow was -7,262,100 USD.
Get free Vistagen Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,250,000 USD
- Operating income
- -10,248,500 USD
- Net income
- -10,255,500 USD
- Operating cash flow
- -7,262,100 USD
Explore related company data
View all 2017 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Vistagen Therapeutics, Inc. financial years